Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05865054

Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)

A Longitudinal Study of Orbital and Cranial Vessel Wall MRI in Giant Cell Arteritis by the Vascular MRI Evaluation in Giant Cell Arteritis (VEGA) Collaborative

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).

Detailed description

After signing the consent form, participants will complete an MRI scan within 2 weeks of enrollment and fill out questionnaires related to their disease. Follow up visits and MRI scans may occur at 6-months after the initial MRI scan or at the time of relapse.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetic Resonance Imaging (MRI)Combined orbital and cranial vessel wall MRI

Timeline

Start date
2020-07-29
Primary completion
2030-07-01
Completion
2033-07-01
First posted
2023-05-18
Last updated
2025-09-19

Locations

4 sites across 3 countries: United States, Canada, Germany

Source: ClinicalTrials.gov record NCT05865054. Inclusion in this directory is not an endorsement.